Annals of SBV

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  11 (2022)
Volume  10 (2021)
Volume  9 (2020)
Volume  8 (2019)
Volume  7 (2018)
Volume  6 (2017)
Volume  5 (2016)
Volume  4 (2015)
Volume  3 (2014)
Volume  2 (2013)
Volume  1 (2012)
Related articles

VOLUME 11 , ISSUE 1 ( January-June, 2022 ) > List of Articles

REVIEW ARTICLE

Management of Donor Site a Bygone Area in Split-skin Grafting

Divya Kumar, CP Ganesh Babu

Keywords : Donor site, Donor-site management, Dressing, Pirfenidone, Split-skin graft

Citation Information : Kumar D, Babu CG. Management of Donor Site a Bygone Area in Split-skin Grafting. 2022; 11 (1):6-9.

DOI: 10.5005/jp-journals-10085-9114

License: CC BY-NC 4.0

Published Online: 18-10-2022

Copyright Statement:  Copyright © 2022; The Author(s).


Abstract

Split-skin grafts contain the entirety of the epidermis and a variable amount of dermis, depending on the thickness of the harvested graft. The process of skin grafting involves the creation of another wound at the donor site, which has to be managed as the donor-site wound, will be more painful due to exposure of sensory nerve endings and distressing to the patient compared with that of the recipient site. In spite of various advances in techniques of grafting, management of the donor site is more or less standard. Donor site should also be managed adequately to avoid complications and promote wound healing. Various methods have been used by practitioners for the management of donor site.

PDF Share
  1. Ratner D. Skin grafting. From here to there. Dermatol Clin 1998; 16(1):75–90. DOI: 10.1016/s0733-8635(05)70488-5.
  2. Beldon P. Comparison of four different dressings on donor site wounds. Br J Nurs 2004;13(Supp 1):S38–S45. DOI: 10.12968/bjon.2004.13.Sup1.12541.
  3. Rinaldi I, Sungkar A, Alifianto U. Epithelial rate difference on donor wound of split thickness skin graft in the thigh area by applying Leukocrepe® and Medicrepe®. Indones J Med 2017;2(3):146–153. DOI: 10.26911/theijmed.2017.02.03.01.
  4. Muangman P, Nitimonton S, Aramwit P. Comparative clinical study of Bactigras and Telfa AMD for skin graft donor-site dressing. Int J Mol Sci 2011;12(8):5031–5038. DOI: 10.3390/ijms12085031.
  5. Otene CI, Olaitan PB, Ogbonnaya IS, Nnabuko R. Donor site morbidity following harvest of split-thickness skin grafts in South Eastern Nigeria. J West Afr Coll Surg 2011;1(2):86–96. PMID: 27182501.
  6. Smith DJ, Thomson, Bolton LL, Hutchinson JJ. Microbiology and healing of the occluded skin-graft donor site. Plastic and Reconstructive Surgery 1993;91(6):1094–1097. DOI: 10.1097/00006534-199305000-00019.
  7. Lars PKLP, Giretzlehner M, Trop M, Parvizi D, Spendel S, Schintler M, et al. The properties of the “ideal” donor site dressing: results of a worldwide online survey. Ann Burns Fire Disasters 2013;26(3):136–141. PMCID: PMC3917148.
  8. Thornton JF. In: Skin Grafts and Skin Substitutes. Selected readings in plastic surgery 2004. p. 78.
  9. Kilinc H, Sensoz O, Ozdemir R, Unlu RE, Baran C. Which dressing for split-thickness skin graft donor sites? Ann Plastic Surg 2001;46(4): 409–414. DOI: 10.1097/00000637-200104000-00010.
  10. Kaiser D, Hafner J, Mayer D, French LE, Läuchli S. Alginate dressing and polyurethane film versus paraffin gauze in the treatment of split-thickness skin graft donor sites: a randomized controlled pilot study. Adv Skin Wound Care 2013;26(2):67–73. DOI: 10.1097/01.ASW.0000426715.57540.8d.
  11. Wiechula R. The use of moist wound-healing dressings in the management of split-thickness skin graft donor sites: a systematic review. Int J Nurs Pract 2003;9(2):S9–S17. DOI: 10.1046/j.1322-7114.2003.00417.x.
  12. Bian Y, Sun C, Zhang X, Li Y, Li W, Lv X, et al. Wound-healing improvement by resurfacing split-thickness skin donor sites with thin split-thickness grafting. Burns 2016;42(1):123–130. DOI: 10.1016/j.burns.2015.07.008.
  13. Karlsson M, Lindgren M, Jarnhed-Andersson I, Tarpila E. Dressing the split-thickness skin graft donor site: a randomized clinical trial. Adv Skin Wound Care 2014;27(1):20–25. DOI: 10.1097/01.ASW.0000437786.92529.22.
  14. Salehi SH, As'adi K, Mousavi SJ, Shoar S. Evaluation of amniotic membrane effectiveness in skin graft donor site dressing in burn patients. Indian J Surg 2015;77(Suppl 1):427–431. DOI: 10.1007/s12262-013-0864-x.
  15. Phillips TJ. Keratinocyte grafts for wound healing. Clin Dermatol 1994;12(1):171–181. DOI: 10.1016/0738-081X(94)90267-4.
  16. Ahmad AE-AIHA, Hemieda M, Badran HA, SEIF II. Cultured allogenic keratinocyte grafts in the treatment of burns: preliminary report. Egypt J Plast Reconstr Surg 2002;26(2):161–165.
  17. Olawoye OA, Ademola SA, Iyun AO, Michael AI, Oluwatosin OM. Management of split skin graft donor site in the West African sub region: survey of plastic surgeons’ practice. Ann Burns Fire Disasters 2017;30(2):146–149. PMCID: PMC5627554.
  18. Läuchli S, Hafner J, Ostheeren S, Mayer D, Barysch MJ, French LE. Management of split-thickness skin graft donor sites: a randomized controlled trial of calcium alginate versus polyurethane film dressing. Dermatology 2013;227(4):361–366. DOI: 10.1159/000356122.
  19. Dhanraj P. A clinical study comparing helicoll with scarlet red and OpSite in the treatment of split thickness skin graft donor sites—a randomized controlled trial. Indian J Surg 2015;77(Suppl 2):385–392. DOI: 10.1007/s12262-013-0850-3.
  20. Dornseifer U, Lonic D, Gerstung TI, Herter F, Fichter AM, Holm C, et al. The ideal split-thickness skin graft donor-site dressing: a clinical comparative trial of a modified polyurethane dressing and aquacel. Plast Reconstr Surg 2011;128(4):918–924. DOI: 10.1097/PRS.0b013e3182268c02.
  21. Brölmann FE, Eskes AM, Goslings JC, Niessen FB, de Bree R, Vahl AC, et al. Randomized clinical trial of donor-site wound dressings after split-skin grafting: donor-site wound dressings after split-skin grafting. Br J Surg 2013;100(5):619–627. DOI: 10.1002/bjs.9045.
  22. Mandapalli PK, Labala S, Bojja J, Venuganti VVK. Effect of pirfenidone delivered using layer-by-layer thin film on excisional wound healing. Eur J Pharm Sci 2016;83:166–174. DOI: 10.1016/j.ejps.2015.12.027.
  23. Pakyari M, Farrokhi A, Maharlooei MK, Ghahary A. Critical role of transforming growth factor beta in different phases of wound healing. Adv Wound Care 2013;2(5):215–224. DOI: 10.1089/wound. 2012.0406.
  24. Mecott-Rivera GÁ, Aguilar-Baqueiro JA, Bracho S, Miranda-Maldonado I, Franco-Márquez R, Castro-Govea Y, et al. Pirfenidone increases the epithelialization rate of skin graft donor sites. Burns 2018;44(8):2051–2058. DOI: 10.1016/j.burns.2018.07.007.
  25. Mecott GA, González-Cantú I, Dorsey-Treviño EG, Matta-Yee- Chig D, Saucedo-Cárdenas O, Montes de Oca-Luna R, et al. Efficacy and safety of pirfenidone in patients with second-degree burns: a proof-of-concept randomized controlled trial. Adv Skin Wound Care 2020;33(4):1–7. DOI: 10.1097/01.ASW.0000655484.95155.f7.
  26. Armendariz-Borunda J, Lyra-Gonzalez I, Medina-Preciado D, Gonzalez-García I, Martinez-Fong D, Miranda RA, et al. A controlled clinical trial with pirfenidone in the treatment of pathological skin scarring caused by burns in pediatric patients. Ann Plast Surg 2012;68(1):22–28. DOI: 10.1097/SAP.0b013e31821b6d08.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.